CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 3
- ScaleRevenue is $938.06M, above the global median of $520.53M
- PositionOperating margin is -7.9%, lower than 95% of its Apparel Retail peers (median 7.3%)
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
315.34MUSDvs all stocks (USD)
Trailing P/E
24.92xvs Apparel Retail peers
Revenue (TTM)
938.06MUSDvs all stocks (USD)
Profit Margin
1.54%vs Apparel Retail peers
Beta
1.00xvs all stocks
52-Week Change
34.46%vs all stocks
Market Capitalization
315.34MUSDvs all stocks (USD)
Enterprise Value
395.01MUSDvs all stocks (USD)
Trailing P/E
24.92xvs Apparel Retail peers
Forward P/E
12.46xvs Apparel Retail peers
PEG Ratio
6.56xvs Apparel Retail peers
Price to Sales (TTM)
0.3362xvs Apparel Retail peers
Price to Book (MRQ)
1.04xvs Apparel Retail peers
Enterprise to Revenue
0.4210xvs Apparel Retail peers
Enterprise to EBITDA
8.27xvs Apparel Retail peers
Gross Margin
31.73%vs Apparel Retail peers
Profit Margin
1.54%vs Apparel Retail peers
Operating Margin
-7.86%vs Apparel Retail peers
Return on Assets (TTM)
2.78%vs Apparel Retail peers
Return on Equity (TTM)
4.78%vs Apparel Retail peers
Revenue (TTM)
938.06MUSDvs all stocks (USD)
Revenue per Share (TTM)
57.57USDUpdated Jul 19, 2026Quarterly Revenue Growth
4.90%vs Apparel Retail peers
Gross Profit (TTM)
339.06MUSDvs all stocks (USD)
EBITDA (TTM)
38.16MUSDvs all stocks (USD)
Net Income (TTM)
14.44MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
4.88%vs Apparel Retail peers
Operating Cash Flow (TTM)
47.46MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
41.46MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 19, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Apparel Retail peers
Revenue
929.06MUSDFY2026 · Jan 31, 2026Cost of Goods Sold
596.52MUSDFY2026 · Jan 31, 2026Gross Profit
332.54MUSDFY2026 · Jan 31, 2026Operating Income
17.04MUSDvs all stocks (USD)
Pre-tax Income
24.06MUSDFY2026 · Jan 31, 2026Income Tax Expense
10.69MUSDFY2026 · Jan 31, 2026Net Income
13.38MUSDFY2026 · Jan 31, 2026EBIT
17.04MUSDFY2026 · Jan 31, 2026EBITDA (Income Statement)
38.16MUSDFY2026 · Jan 31, 2026Selling, General & Administrative
315.49MUSDFY2026 · Jan 31, 2026Non-operating Interest Income
4.67MUSDFY2026 · Jan 31, 2026EPS (Basic)
0.8000USDFY2026 · Jan 31, 2026EPS (Diluted)
0.7800USDFY2026 · Jan 31, 2026Basic Shares Outstanding
16.77MSharesFY2026 · Jan 31, 2026Diluted Shares Outstanding
16.77MSharesFY2026 · Jan 31, 2026Net Income from Continuing Operations
13.38MUSDFY2026 · Jan 31, 2026Operating Cash Flow
46.40MUSDFY2026 · Jan 31, 2026Free Cash Flow
35.34MUSDFY2026 · Jan 31, 2026Cash & Cash Equivalents (End of Period)
134.11MUSDFY2026 · Jan 31, 2026Starting Profit (CF Statement)
13.38MUSDFY2026 · Jan 31, 2026Depreciation & Amortization
21.12MUSDFY2026 · Jan 31, 2026Deferred Taxes (CF)
2.61MUSDFY2026 · Jan 31, 2026Stock-based Compensation
7.27MUSDFY2026 · Jan 31, 2026Other Non-cash Items
63.99MUSDFY2026 · Jan 31, 2026Change in Accounts Receivable (CF)
2.25MUSDFY2026 · Jan 31, 2026Change in Accounts Payable (CF)
-2.26MUSDFY2026 · Jan 31, 2026Change in Other Assets/Liabilities
-61.95MUSDFY2026 · Jan 31, 2026Capital Expenditures
-11.06MUSDFY2026 · Jan 31, 2026Purchase of Investments
-23.10MUSDFY2026 · Jan 31, 2026Sale of Investments
27.77MUSDFY2026 · Jan 31, 2026Net Investing Cash Flow
-6.39MUSDFY2026 · Jan 31, 2026Long-term Debt Issuance
6.89MUSDFY2026 · Jan 31, 2026Long-term Debt Payments
-6.89MUSDFY2026 · Jan 31, 2026Common Stock Repurchase
-38.25MUSDFY2026 · Jan 31, 2026Net Financing Cash Flow
-38.25MUSDFY2026 · Jan 31, 2026Shares Outstanding
17.03MSharesUpdated Jul 19, 2026Float Shares
12.95MSharesUpdated Jul 19, 2026Shares Short
1.21MSharesUpdated Jul 19, 2026Short Ratio
3.99daysvs all stocks
Short % of Shares Outstanding
9.34%vs all stocks
% Held by Insiders
23.22%vs all stocks
% Held by Institutions
80.83%vs all stocks
Total Cash (MRQ)
124.16MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
7.36USDUpdated Jul 19, 2026Total Debt (MRQ)
203.83MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.6664xvs Apparel Retail peers
Current Ratio (MRQ)
1.95xvs Apparel Retail peers
Book Value per Share (MRQ)
17.96USDUpdated Jul 19, 2026Total Assets
644.17MUSDvs all stocks (USD)
Total Current Assets
335.98MUSDFY2026 · Jan 31, 2026Total Liabilities
319.89MUSDFY2026 · Jan 31, 2026Total Non-current Assets
308.19MUSDFY2026 · Jan 31, 2026Total Non-current Liabilities
152.36MUSDFY2026 · Jan 31, 2026Total Current Liabilities
167.53MUSDFY2026 · Jan 31, 2026Cash
93.61MUSDFY2026 · Jan 31, 2026Cash Equivalents
34.25MUSDFY2026 · Jan 31, 2026Cash & Cash Equivalents
127.86MUSDFY2026 · Jan 31, 2026Other Short-term Investments
32.76MUSDFY2026 · Jan 31, 2026Accounts Receivable
5.47MUSDFY2026 · Jan 31, 2026Inventory
147.00MUSDFY2026 · Jan 31, 2026Accounts Payable
49.15MUSDFY2026 · Jan 31, 2026Short-term Debt
54.02MUSDFY2026 · Jan 31, 2026Deferred Revenue
5.24MUSDFY2026 · Jan 31, 2026Other Current Liabilities
1.32MUSDFY2026 · Jan 31, 2026Long-term Debt
145.31MUSDFY2026 · Jan 31, 2026Other Non-current Liabilities
7.05MUSDFY2026 · Jan 31, 2026Common Stock (Book)
211.76MUSDFY2026 · Jan 31, 2026Retained Earnings
123.96MUSDFY2026 · Jan 31, 2026Total Shareholders' Equity
324.29MUSDvs all stocks (USD)
52-Week Low
13.08USDUpdated Jul 19, 202652-Week High
31.70USDUpdated Jul 19, 202652-Week Change
34.46%vs all stocks
Beta
1.00xvs all stocks
50-Day MA
20.50USDUpdated Jul 19, 2026200-Day MA
23.23USDUpdated Jul 19, 2026Avg 10-Day Volume
188.63KSharesUpdated Jul 19, 2026Avg 30-Day Volume
278.64KSharesUpdated Jul 19, 2026Diluted EPS (TTM)
0.7500USDUpdated Jul 19, 2026Other Income / Expense
2.35MUSDFY2026 · Jan 31, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Diagnostic
High Equity Share With Elevated Lease Share of Assets
Little debt against its assets, but leases are a large share of what it holds.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -7.9%, lower than 95% of its Apparel Retail peers (median 7.3%)Significant
Operating margin: -0.08Industry median: 0.07Industry P5: 0.01Peers compared: 27.00
Financial Health
Altman Z-Score 2.7: safe zoneNotable
Altman Z-Score: 2.70
Supply Chain
Upstream position: supplies 5 industries, depends on 3Notable
Outgoing: 5.00Incoming: 3.00
Scale
Revenue is $938.06M, above the global median of $520.53MNotable
Revenue (USD): 938,062,016Global Median: 520,528,949.311
Levered free cash flow is $41.46M, above the global median of $16.24MNotable
Levered free cash flow (USD): 41,457,624Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Giordano International Limited
Tier 1FlowUnit ReplicationRiskInterface
Vertu Motors plc
Tier 1FlowUnit ReplicationInterfaceRisk
Bintang Oto Global Tbk.
Tier 1FlowUnit ReplicationInterfaceRisk
Shanghai Pioneer Holding Ltd.
Tier 1FlowUnit ReplicationInterfaceRule
Card Factory plc
Tier 1FlowUnit ReplicationInterfaceProduction
Retailors Ltd.
Tier 1FlowUnit ReplicationInterfaceRisk
PTG Energy Public Company Limited
Tier 1FlowUnit ReplicationInterfaceProduction
Lands' End Inc.
Tier 1FlowUnit ReplicationRiskInterface
Retail Partners Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceRisk
Xebio Holdings Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceAttention
Companies that share active interpretations — structural patterns currently present in both stocks.
Century Therapeutics, Inc.
1 interpretationHigh Equity Share With Elevated Lease Share of Assets
Lyell Immunopharma, Inc.
1 interpretationHigh Equity Share With Elevated Lease Share of Assets
Troops Inc.
1 interpretationHigh Equity Share With Elevated Lease Share of Assets